Anacor Pharmaceutica (ANAC) 99.06 $ANAC Pfizer on

New Post Public Reply Private Reply Replies (0) Message Board

Sep 1, 2016 at 7:12 PM

Anacor Pharmaceutica (ANAC) 99.06 $ANAC

Pfizer on buying spree with AstraZeneca antibiotics deal
By LINDA A. JOHNSON - AP - Wed Aug 24, 4:11PM CDT
TRENTON, N.J. (AP) — Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland.
AGN: 237.76 (+3.22), AZN: 32.60 (-0.21), PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

Hercules Announces Strong Second Quarter Financial Results with $0.32 NII per Share and a $0.31 Quarterly Dividend
BusinessWire - Thu Aug 04, 3:05PM CDT
--Q2 2016 Financial Highlights
TPIC: 19.79 (-0.10), HTGC: 13.69 (+0.03), NUAN: 14.60 (+0.02), PFE: 34.68 (-0.12), BIND: 0.78 (-0.09), RLOC: 4.60 (unch), CPXX: 30.24 (unch), HTGY: 25.84 (unch), HTGZ: 25.59 (+0.09), GCI: 11.77 (-0.16), HTGX: 26.14 (+0.12), JAZZ: 123.31 (-0.52), ANAC: 99.06 (-0.14), EACQ: 9.73 (-0.15)

Why Pfizer (PFE) is a Great Stock to Buy for the Long Run
Maher Syed - Zacks Investment Research - Thu Jun 23, 7:37PM CDT
Pfizer has a great dividend, and it generates an incredibly high level of sales, but here's why else this stock is worth keeping in your portfolio for the long haul.
AGN: 237.76 (+3.22), PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

Stock Market News for May 23, 2016
Zacks Equity Research - Zacks Investment Research - Mon May 23, 9:10AM CDT
Benchmarks closed in positive territory on Friday following speculations that indications of a Fed rate hike signal that the economy may be strengthening
TSLA: 200.77 (-11.24), HD: 134.23 (+0.11), FB: 126.17 (+0.05), PFE: 34.68 (-0.12), WMT: 72.84 (+1.40), INTC: 36.02 (+0.13), GS: 168.51 (-0.95), IBM: 159.54 (+0.66), AMAT: 30.29 (+0.45), TGT: 70.58 (+0.39), ANAC: 99.06 (-0.14), GOOGL: 791.40 (+1.55), FL: 65.53 (-0.11), BRK.B: 150.35 (-0.14), AAPL: 106.73 (+0.63)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor Pharmaceuticals, Inc.
BusinessWire - Fri May 20, 9:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Anacor Pharmaceuticals, Inc. ("Anacor" or "the Company"

(Nasdaq: ANAC) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pfizer, Inc. ("Pfizer"

.
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into Whether the Sale of Anacor Pharmaceuticals, Inc. to Pfizer Inc. for $99.25 Per Share is Fair to Shareholders
BusinessWire - Fri May 20, 3:43PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

ANACOR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Anacor Pharmaceuticals, Inc. (ANAC) Over the Proposed Sale of the Company to Pfizer Inc.
BusinessWire - Fri May 20, 1:08PM CDT
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Anacor Pharmaceuticals, Inc. ("Anacor" or the "Company"

(Nasdaq:ANAC) for potential breaches of fiduciary duties in connection with the sale of the Company to Pfizer Inc. for approximately $5.2 billion.
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

The Zacks Analyst Blog Highlights: Medivation, Anacor, Aduro, Trevena and Tetraphase
Zacks Equity Research - Zacks Investment Research - Fri May 20, 8:30AM CDT
The Zacks Analyst Blog Highlights: Medivation, Anacor, Aduro, Trevena and Tetraphase
MDVN: 80.93 (+0.37), TTPH: 3.78 (-0.02), TRVN: 6.77 (-0.01), ADRO: 14.22 (+0.13), ANAC: 99.06 (-0.14)

Are These Biotech Stocks Prescribed for Investors' Portfolio? - Anacor Pharma, Athersys, Aralez Pharma and Infinity Pharma
PR Newswire - Fri May 20, 7:10AM CDT
The Biotech arena remains under immense pressure, yet many veteran investors believe that the industry is not far from recovering. There are great companies in this space, and today ActiveWallSt.com featured the following four equities: Anacor Pharmaceuticals Inc. (NASDAQ: ANAC), Athersys Inc. (NASDAQ: ATHX), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ), and Infinity Pharmaceuticals Inc. (NASDAQ: INFI). Sign up for your free trading alerts on these biotech stocks at:
INFI: 1.52 (unch), ARLZ: 5.02 (+0.05), ANAC: 99.06 (-0.14), ATHX: 1.94 (+0.03)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of Anacor Pharmaceuticals, Inc. -ANAC
PR Newswire - Thu May 19, 9:10PM CDT
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Anacor Pharmaceuticals, Inc. ("Anacor" or "the Company"

(Nasdaq- ANAC-News) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Pfizer, Inc. ("Pfizer"

.
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

Biotech Stock Roundup: Pfizer to Buy Anacor for $5.2B, Pipeline Setbacks for Aduro, Trevena
Arpita Dutt - Zacks Investment Research - Thu May 19, 2:36PM CDT
Key highlights in the biotech sector include the acquisition agreement between Anacor (ANAC) and Pfizer as well as data presentations.
MDVN: 80.93 (+0.37), TRVN: 6.77 (-0.01), TTPH: 3.78 (-0.02), VRTX: 94.75 (+0.24), ADRO: 14.22 (+0.13), AMGN: 170.13 (+0.07), ANAC: 99.06 (-0.14)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Regarding the Fairness of the Sale of Anacor Pharmaceuticals, Inc. to Pfizer Inc. for $99.25 Per Share
BusinessWire - Thu May 19, 12:33PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

Anacor Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Investigate Merger with Pfizer, Inc.
BusinessWire - Wed May 18, 3:28PM CDT
Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Anacor Pharmaceuticals, Inc. ("Anacor"

(NASDAQ: ANAC) concerning the merger with Pfizer, Inc. Under the terms of the agreement, valued at approximately $5.2 billion, Anacor shareholders will only receive $99.25 in cash per share held.
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

Ryan & Maniskas, LLP Announces Investigation of Anacor Pharmaceuticals, Inc.
PR Newswire - Wed May 18, 9:41AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Anacor Pharmaceuticals, Inc. ("Anacor" or the "Company"

(NASDAQ: ANAC) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to Pfizer Inc. in a transaction valued at approximately $5.2 billion.
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

INVESTOR ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Anacor Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information
BusinessWire - Tue May 17, 4:32PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Anacor Pharmaceuticals, Inc. ("Anacor" or the "Company"

(Nasdaq: ANAC) relating to the proposed buyout of the Company by Pfizer Inc.
ANAC: 99.06 (-0.14)

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of Anacor Pharmaceuticals, Inc. to Pfizer Inc. for $99.25 Per Share -- ANAC
PR Newswire - Tue May 17, 1:44PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

Block & Leviton LLP Investigates Anacor Pharmaceuticals Inc., Inc. for Possible Breaches of Fiduciary Duty in Connection with Its Acquisition by Pfizer Inc.
PR Newswire - Tue May 17, 12:26PM CDT
Block & Leviton LLP (www.blockesq.com), a Boston-based law firm representing investors nationwide, has commenced an investigation into possible breaches of fiduciary duty by the Board of Directors of Anacor Pharmaceuticals Inc. ("Anacor" or the "Company"

(NASDAQ: ANAC) concerning the proposed acquisition of the Company by Pfizer Inc. ("Pfizer"

in an all-cash transaction.
PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14)

Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
Sweta Killa - Zacks Investment Research - Tue May 17, 10:40AM CDT
Pfizer struck a deal to acquire the skin drug maker Anacor Pharmaceuticals for $5.2 billion that sent biotech ETFs higher.
AGN: 237.76 (+3.22), PBE: 40.33 (+0.17), SBIO: 24.18 (+0.08), FBT: 96.15 (+0.33), XBI: 60.34 (+0.25), PFE: 34.68 (-0.12), BBH: 113.79 (+0.10), IBB: 281.44 (+0.55), ANAC: 99.06 (-0.14)

Pfizer to Buy Anacor, Add Eczema Treatment to Portfolio
Arpita Dutt - Zacks Investment Research - Tue May 17, 7:13AM CDT
Pfizer (PFE) maintained its 2016 guidance but expects the deal to be earnings dilutive in 2017 and accretive thereafter.
MDVN: 80.93 (+0.37), AGN: 237.76 (+3.22), PFE: 34.68 (-0.12), ANAC: 99.06 (-0.14), BMY: 56.76 (-0.63)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BLM's Wild Horse Strategy: Fertility Control's Time to Shine

Wild Horse Management Gets a Shot in the Arm Amigo, when the federal government throws $30 million dollars at a problem, you'd hope they're not just throwing us a bone. The Bureau of Land Management (BLM) now has this hefty sum courtesy of the U.S. Department of Agriculture, intended to expand wild horse fertility control across the sprawling landscapes they roam. This...

Multiply's AI Agent Tackles $126K Google Ads Waste

AI Steps In Where Marketers Hit a Wall Picture this: marketers drowning in search terms flying at them faster than they can blink. Multiply's new AI-powered Ad Spend Recovery Agent steps in, claiming to save an eye-watering $126,000 per year by cutting Google Ads waste. Talk about having a hawk-eyed auditor sifting through your accounts. Shaking Up Traditional Automation...

HiBy Unveils Cyberpunk 2077 Gaming Audio Line

HiBy Hits the Gaming Scene with Cyberpunk Flair It's a wild world when audio tech and gaming collide outside of the usual suspects. HiBy's latest move is a bold pivot into the gaming universe, launching an audacious collaboration with, of all things, the cybernetic chaos of Cyberpunk 2077. You can almost feel the underlying scrappiness of Night City embedded into a couple...

Klydoclock's Bold Move: Licensing International Boost

Revolutionizing Timekeeping with Art There’s this clock outfit, Klydoclock, that’s flipping the script on how we see time and art melding together. You see, they’ve taken those static old tick-tock reminders of the hour and juiced 'em up with animated art, turning your wall clock into something more akin to a mini art exhibit right in your living room. Ever heard of...

Alito's Recusal: Supreme Court Climate Case Shaker

Justice Alito Bows Out from A High-Stakes Climate Battle September 28, 2026, marked a notable turn in the legal landscape. Supreme Court Justice Samuel Alito chose to step away from a case that's got every investor, lawyer, and policy wonk on the edge of their seats—Suncor v. Boulder. This isn't about just any old courtroom squabble; it's a landmark climate case poised...

Schweid & Sons Reveals New Marinated Steak Tips Line

No More Prep Dilemmas: Schweid & Sons Unveils Steak Tips Packing a punch in the protein aisle, Schweid & Sons throws down the gauntlet with their latest culinary innovation — Marinated Steak Tips. These aren't just your run-of-the-mill cuts, folks. We're talking premium Tri-Tip, butcher-trimmed to perfection, and marinated in both Cajun and Teriyaki styles. It's all...

Claigan Webinar Tackles Prop 65 Warnings for 2028

Buckle up, folks. Here comes a wake-up call for businesses playing loose with their compliance homework on California's Prop 65, thanks to Claigan's latest announcement. They're hosting a webinar on October 7, 2026, gearing up everyone who'll listen for the changes hitting the books in 2028. We’re zooming past the days of generic warnings; pretty soon, it'll be all...

Beasley and Vegas Golden Knights Partner for Broadcast

Strategic Moves on the Airwaves The Vegas Golden Knights are skating into a new era of broadcasting. Teaming up with Beasley Media Group, they've inked a multiyear deal that makes the media outfit their official audio partner. Dropping the puck on this relationship means folks in Southern Nevada can catch the action on Beasley's English and Spanish stations. It's a hefty...

Gray's Rise in ENR Rankings Highlights Sector Dominance

Gray's Outstanding Reputation in the Construction Arena Nothing says “we're on top of our game” like snatching top slots in industry rankings, and that's precisely what Gray, the construction and engineering heavyweight, has managed to do. This firm recently secured impressive spots across ten different categories in the prestigious Engineering News-Record (ENR) Top...

Hyundai Teases 2027 TUCSON: Global Reveal Imminent

Hyundai Sets the Stage for the 2027 TUCSON Hyundai’s ready to roll out its shiny new set of wheels, the 2027 TUCSON, and boy, they sure know how to make an entrance. Mark your calendars for October 1—it's happening right in the Big Apple, none other than Long Island City. Expect the spotlight to hit at precisely 5:15 p.m. ET, and don't worry if you can't snag a...